You can purchase shares of Immix Biopharma (NASDAQ:IMMX) through any online brokerage.

View our list of the best stock brokerages

Other companies in Immix Biopharma’s space includes: Tectonic Therapeutic Inc (NASDAQ:TECX), Larimar Therapeutics Inc (NASDAQ:LRMR), Altimmune Inc (NASDAQ:ALT), Prothena Corp PLC (NASDAQ:PRTA) and ADC Therapeutics SA (NYSE:ADCT).

Immix Biopharma has a consensus price target of $15.75.

The stock price for Immix Biopharma (NASDAQ: IMMX) is $10.15 last updated March 9, 2026 at 6:54 PM EDT.

There are no upcoming dividends for Immix Biopharma.

Immix Biopharma does not have any upcoming earnings scheduled.

There is no upcoming split for Immix Biopharma.

Immix Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.